脑部放疗，上午比下午敏感许多！
0 `6 o. C. J) ~( O
4 W* a( y. X4 Z7 {9 B6 E% ]7 }. c
( w9 x& D! O; f }5 J* q: XCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9./ {8 N4 F- y$ K, S O# A
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
; B X3 h& ~$ x. b, x) H) E/ `Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
9 i& S8 U/ U0 e# D! X4 ^SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
5 Z5 f# m' u4 A, a [4 y
9 w7 J( h! |' k' m S. B8 }( A! E. PAbstract
' G( \7 V3 S& H% M: i& O6 y* n* q2 k! EBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
* L( Y0 p8 A6 T7 ^; W! E
0 Z" H9 }5 X# v( p3 @METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
/ N( B* S4 x8 u
$ i, Z& o/ [2 M: h7 t3 _RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
, A* F% r1 _$ u( o0 ^# Q, Q3 i+ i9 i0 z& ~: _* ~
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.9 e4 h% r5 ~3 |' d0 G
( x9 C( j+ J- h5 N/ ~ V( n* N# q
|
显身卡
